Mutual of America Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-9,169
| Closed | -$305K | – | 1488 |
|
|
2022
Q4 | $305K | Buy |
9,169
+466
| +5% | +$15.5K | ﹤0.01% | 1261 |
|
|
2022
Q3 | $274K | Buy |
8,703
+1,385
| +19% | +$43.6K | ﹤0.01% | 1266 |
|
|
2022
Q2 | $223K | Buy |
7,318
+1,044
| +17% | +$31.8K | ﹤0.01% | 1295 |
|
|
2022
Q1 | $163K | Buy |
6,274
+351
| +6% | +$9.12K | ﹤0.01% | 1414 |
|
|
2021
Q4 | $121K | Buy |
5,923
+143
| +2% | +$2.92K | ﹤0.01% | 1484 |
|
|
2021
Q3 | $111K | Sell |
5,780
-380
| -6% | -$7.3K | ﹤0.01% | 1502 |
|
|
2021
Q2 | $137K | Buy |
6,160
+398
| +7% | +$8.85K | ﹤0.01% | 1493 |
|
|
2021
Q1 | $151K | Buy |
5,762
+369
| +7% | +$9.67K | ﹤0.01% | 1445 |
|
|
2020
Q4 | $101K | Buy |
5,393
+195
| +4% | +$3.65K | ﹤0.01% | 1474 |
|
|
2020
Q3 | $88K | Buy |
5,198
+3,128
| +151% | +$53K | ﹤0.01% | 1421 |
|
|
2020
Q2 | $48K | Buy |
2,070
+193
| +10% | +$4.48K | ﹤0.01% | 1351 |
|
|
2020
Q1 | $16K | Buy |
1,877
+355
| +23% | +$3.03K | ﹤0.01% | 1536 |
|
|
2019
Q4 | $15K | Sell |
1,522
-59
| -4% | -$581 | ﹤0.01% | 1617 |
|
|
2019
Q3 | $15K | Buy |
1,581
+54
| +4% | +$512 | ﹤0.01% | 1608 |
|
|
2019
Q2 | $18K | Buy |
1,527
+318
| +26% | +$3.75K | ﹤0.01% | 1584 |
|
|
2019
Q1 | $21K | Buy |
1,209
+153
| +14% | +$2.66K | ﹤0.01% | 1516 |
|
|
2018
Q4 | $18K | Buy |
1,056
+251
| +31% | +$4.28K | ﹤0.01% | 1498 |
|
|
2018
Q3 | $12K | Buy |
805
+649
| +416% | +$9.68K | ﹤0.01% | 1601 |
|
|
2018
Q2 | $2K | Buy |
+156
| New | +$2K | ﹤0.01% | 1647 |
|
|
2016
Q4 | – | Sell |
-2,400
| Closed | -$46K | – | 1226 |
|
|
2016
Q3 | $46K | Hold |
2,400
| – | – | ﹤0.01% | 1185 |
|
|
2016
Q2 | $47K | Buy |
+2,400
| New | +$47K | ﹤0.01% | 1185 |
|